Samsung Biologics speeds up $1.5 billion fifth plant, CEO reveals at BIO 2023

Published on June 16, 2023

Samsung Biologicsâ upcoming fifth plant will be operational by April 2025, five months earlier than previously expected, the biotech company revealed at BIO International Convention on Monday 5.

Continue reading on website
Other news

Encouraging results for Parkinson's Disease drug in Biovie study as more patients retain sufficient muscle control

June 16, 2023
Encouraging clinical data has been released by Biovie, a company developing drug therapies for the treatment of neurological and neurodegenerative disorders and advanced liver disease.

Axol and StrataStem link up for Alzheimer’s disease trial

June 16, 2023
Companies will incorporate cells and technology to create a ‘clinical trial in a dish’